A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104
Clinical trial NCT04349969 · COMPLETED
Trial details
- NCT number
- NCT04349969
- Sponsor
- Akesobio Australia Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-23
- Primary completion
- 2022-11-08
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.